Medical News Podcast cover art

All Episodes

Medical News Podcast — 415 episodes

#
Title
1

Targeting the OX40 Pathway in Atopic Dermatitis: Lessons Learned From Recent Clinical Data

2

Secondary Prevention of Non-Cardioembolic Ischemic Stroke

3

Minimal Residual Disease (MRD) in CLL: Clinical Utility and Practicality

4

Should some patients remain on dual antiplatelet therapy beyond one year after multivessel PCI?

5

How easy is it to get prescription GLP-1s online?

6

Approaches to Pharmacotherapy in ILD, IPF, and PPF

7

Hearing aids help slow brain aging process in adults with mild cognitive impairment

8

Retinal Disease Updates from AAO 2025

9

Could switching direct oral anticoagulants after breakthrough stroke be unnecessary?

10

Are we entering a new frontline era for HER2-positive gastroesophageal cancer?

11

Evolving Strategies in Obstructive Hypertrophic Cardiomyopathy Management

12

Can two common ICU treatments actually do more harm than good?

13

Bispecific Biologics in Atopic Dermatitis: Opportunities, Challenges, and Clinical Implications

14

ATTR-CM in Focus: New Insights on Survival, Arrhythmias, and Phenotype From ACC 2026

15

Personalizing Migraine Care: Integrating Behavioral Therapies and Complementary Medicine

16

Can We Predict Kidney Function Decline in Patients With Lupus Nephritis?

17

Can artificial intelligence prevent a life-threatening hypoglycemic event before it happens?

18

Beyond Asthma and Eczema: Navigating Biologics for Multimorbid Allergic Patients

19

Has the HPV vaccine already eliminated cervical cancer deaths in a generation of young women?

20

Vaccination and Response in Patients With CLL

21

NCCN 2026 Breast Cancer Congress Updates

22

49th Annual Macula Society Meeting: New and Emerging Treatments for Retinal Diseases

23

Can we actually slow the progression of type 1 diabetes after diagnosis?

24

Revisiting Atopic March in the Era of Type 2 Inflammation

25

Can one kidney drug expand treatment to millions more patients?

26

Early Diagnosis: Screening for ATTR-CM in HFpEF and Aortic Stenosis Populations

27

Highlights From ISC 2026: Uncontrolled Hypertension Among Stroke Survivors, PFO Guidelines Updates, and Clinical Trial Participation Benefit

28

Recognizing Cardiovascular Risk in Patients With Lupus Nephritis

29

Could the current Ebola outbreak expose cracks in global public health?

30

AI, Machine Learning, and HRCT in ILD: Challenges and Future Opportunities

31

How Long Is Too Long? Maintenance Therapy for Patients With Lupus Nephritis

32

Facial Pain, Migraine, and the Trigeminal System

33

CLL at ASH 2025: Time Limited Triplet, Timing of Anti-CD20 Therapy, and GAIA/CLL13

34

2026 Macula Society Meeting: New Developments for Retinal Diseases

35

HER2+ Genitourinary Cancers: Targeted Therapy Highlights From ESMO 2025

36

Could a new oral pan-RAS inhibitor finally change the outlook for KRAS-mutated pancreatic cancer?

37

ATTR-CM in 2026: Stabilizers vs Silencers – How Are You Choosing?

38

Highlights From ISC 2026: The CREST-2 Cognitive Substudy and Oral Health and Stroke Risk

39

AI, Machine Learning, and HRCT in ILD: Fibrosis Quantification

40

HER2 in Genitourinary Cancers: Clinical Relevance and Real-World Testing Considerations

41

Could first-line ablation soon replace antiarrhythmic drugs for persistent atrial fibrillation?

42

CLL and ASH 2025: CAR T-cell Therapy and Data on Vaccination and Cancer Screening

43

Could survival in metastatic pancreatic cancer finally be improving?

44

Obstructive Hypertrophic Cardiomyopathy: The Role of Septal Reduction Therapy in the Current Era of Cardiac Myosin Inhibitors

45

Can shingles vaccine drastically cut risk of serious cardiac events?

46

Key Themes From the 49th Annual Macula Society Meeting

47

CGRP and Women’s Health: Migraine Across the Hormonal Lifespan

48

Can stable post-MI patients safely stop beta-blockers after 1 year?

49

AI, Machine Learning, and HRCT in ILD: Standardizing Diagnostics

50

Could giving whole blood in the field improve survival in patients with traumatic hemorrhage?

51

Highlights From ISC 2026: Insights Into Secondary Stroke Prevention From the OCEAN-STROKE Trial

52

CLL at ASH 2025: CLL17

53

Neuromodulation in Migraine Care: Insights From the 2025 IHS Guidelines

54

Diagnosing Obstructive Hypertrophic Cardiomyopathy: Key Considerations for Clinicians

55

ACR 2025: Risk of Proteinuria in Patients With Lupus Nephritis and the Timing of Kidney Biopsy in Patients With SLE

56

Could anticoagulant choice cut bleeding risk in half for patients with acute VTE?

57

2025 San Antonio Breast Cancer Symposium: Evolving First-Line Approaches in Metastatic HER2+ Breast Cancer

58

Could personalized breast screening replace annual mammograms?

59

HER2+ Strategies in GI Cancers: ESMO 2025 Insights

60

Could a new anti-CD20 therapy transform the treatment for systemic lupus?

61

2025 San Antonio Breast Cancer Symposium: Maintenance Therapy Updates in Metastatic HER2+ Breast Cancer

62

ACR 2025: Mortality Risk With Belimumab and GLP-1 Agonists in Lupus and Lupus Nephritis

63

New Data on Risk Factors and Treatment Regimens for Patients With Neovascular AMD and DME

64

Can oral semaglutide reduce heart failure events in patients with heart failure with preserved ejection fraction?

65

2025 San Antonio Breast Cancer Symposium: Key Updates in Early-Stage HER2+ Breast Cancer

66

CLL at ASH 2025: BRUIN Studies and a Triplet for Richter Transformation

67

Could new pulmonary embolism guidelines safely reduce hospitalizations for some patients?

68

Evolving HER2+ Testing and Targeted Therapies in GI Cancers: Latest Insights From ESMO 2025

69

OnabotulinumtoxinA and Migraine: Clinical Insights and Recent Evidence

70

Can achieving prediabetes remission cut CV death and heart failure risk?

71

HER2+ Endometrial and Ovarian Cancers: Targeted Therapy Highlights From ESMO 2025

72

HER2+ Endometrial and Ovarian Cancers

73

Can an oral PCSK9 inhibitor finally close the LDL gap for high-risk patients?

74

Are UTIs being over treated via telehealth—and who actually needs antibiotics?

75

Sequencing Targeted Therapies in the Management of Patients With CLL

76

What does current evidence show about acetaminophen use in pregnancy?

77

Should clinicians routinely ask patients about firearm access?

78

Are missed 2-month vaccines the strongest warning sign for future MMR refusal?

79

Do GLP-1 weight-loss drugs also reduce asthma attacks in teens?

80

What happens to factor Xa reversal strategies now that andexanet is leaving the U.S.?

81

HER2+ Lung Cancer at ESMO 2025

82

HER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations

83

HER2+ Lung Cancer Breakthroughs: New Targeted Therapies Explained

84

Does tirzepatide offer comparable cardiovascular safety to GLP-1 therapy in diabetes?

85

Veterans and Interstitial Lung Disease: Risk Prediction Models and Early Detection

86

Veterans and Interstitial Lung Disease: Providing Specialized Care in Rural and Underserved Areas

87

Highlights From CHEST 2025: Proactive Intervention and Precision Medicine

88

Should remission—not delay—be the new goal for prediabetes?

89

Highlights From CHEST 2025: Earlier Detection and Targeted Interventions

90

Managing CNS Disease in HER2+ Breast Cancer

91

The Changing Landscape of Therapy in HER2-Low and Ultralow Breast Cancer (Part 2)

92

What are the potential health and safety implications for children now that a CDC advisory panel has moved to withdraw the universal birth-dose recommendation for the hepatitis B vaccine in newborns?

93

The Changing Landscape of Therapy in HER2-Low and Ultralow Breast Cancer (Part 1)

94

Updated 2025 Recommendations: Allo-HCT and CAR T-Cell Therapy in CLL (Part 2)

95

Updated 2025 Recommendations: Allo-HCT and CAR T-Cell Therapy in CLL (Part 1)

96

Could a routine antibiotic quietly trigger severe respiratory failure in young patients?

97

Emerging Therapeutics and Biosimilars: Advancing the Future of Osteoporosis Care

98

Sequential Therapy and Switching Strategies in Osteoporosis: Insights for Improved Outcomes

99

How much can staying active in adulthood realy cut dementia risk?

100

Advanced Imaging in Osteoporosis: Integrating Trabecular Bone Score for Enhanced Fracture Risk Assessment

101

How are major medical societies responding to FDA changes to menopause therapy labels?

102

Could over-the-counter painkillers truly outperform opioids after dental surgery?

103

Managing CNS Involvement in HER2+ Lung Cancer

104

Could a chemo-free regimen surpass the standard triplet in HER2+ Breast Cancer?

105

Evolving Second-Line Strategies in HER2+ Lung Cancer

106

First-Line Strategies in HER2+ Lung Cancer

107

Can HER2+ Metastatic Breast Cancer Be Cured?

108

What the PATINA Trial Teaches Us About Treating HER2+ Breast Cancer

109

Could there be a long-awaited breakthrough in first-line therapy for triple-negative breast cancer?

110

Early-Stage HER2+ Breast Cancer

111

Could the choice of diabetes medication change a patient’s cardiovascular risk?

112

Do updated COVID vaccines protect U.S. veterans from severe outcomes?

113

When can stage II–III colon cancer be considered cured after treatment?

114

ICML 2025: Novel Agents in CLL

115

Could SGLT2 inhibitors help lower the risk of sudden cardiac death?

116

ICML 2025: Regimens for Patients With High-Risk CLL

117

ICML 2025: Fixed-Duration and MRD-Guided Regimens in CLL

118

CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

119

Should children under 4 still get the MMRV vaccine? The American Academy of Pediatrics says yes

120

Breaking the Migraine Cycle: Understanding Medication Overuse Headache

121

Future Directions in Small Cell Lung Cancer Treatment

122

Small Cell Lung Cancer: Second-line Options Following Maintenance

123

Perspectives on Maintenance Therapy in Small Cell Lung Cancer

124

Should clopidogrel replace aspirin as the standard for CAD prevention?

125

Treat to Target: What it Is and How to Implement

126

Earlier Use of Biologics for Treating Lupus

127

Is FDA-backed elastography poised to replace biopsy as the driver of MASH drug development?

128

2025 Guideline Summary for the Clinical Treatment and Management of Systemic Lupus Erythematosus

129

Emerging Therapies in SLE: Recent Studies and Potential Game-Changing Treatments

130

Non-Invasive Biomarkers in SLE: A Promise of Better Diagnosis, Management, and Personalized Treatment?

131

New Guidelines for the Screening, Treatment, and Management of Lupus Nephritis

132

What does FDA’s approval of generic liraglutide mean for obesity care?

133

How will the first approval for MASH with fibrosis alter treatment pathways?

134

How are telehealth abortion prescriptions reaching ban states?

135

Can a smartphone app reduce suicide attempts after psychiatric hospitalization?

136

Can blood tests reliably guide Alzheimer’s diagnosis in patients with cognitive decline?

137

How do sulfonylureas compare to DPP-4 inhibitors for cardiovascular safety in T2D?

138

Could methotrexate replace prednisone as first-line therapy in lung sarcoidosis?

139

Geographic Atrophy: Where Do We Stand and Where are We Going?

140

Advances in Retinal Therapy: Emerging Strategies for DME and wAMD

141

Richard Ostfeld on Tick-Borne Threats in Changing Ecosystems

142

AI and Telehealth in Diabetic Retinopathy: From Screening to Specialist Care

143

GLP-1s and the Retinal Patient: What Every Eye Care Professional Should Know

144

Floaters: Imaging Tools, Decision-Making, Including Surgery and Patient Counseling

145

Geographic Atrophy: Navigating the Latest Advances in Care

146

“What does full FDA approval of Moderna’s COVID vaccine mean for high-risk kids under 12?”

147

Maintenance Therapy Strategies in Small Cell Lung Cancer

148

ASCO 2025: Emerging Therapies in Small Cell Lung Cancer

149

ASCO 2025: Updates in Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

150

How many avoidable deaths could occur by 2030 if abrupt funding cuts to USAID are not reversed?

151

What’s the latest on the national outbreak of Measles in the US?

152

ASCO 2025 Insights Into HER2+ Breast Cancer: DESTINY-Breast06, SHR-A1811, Rechallenge With T-DXd Post Grade 1 ILD, and More

153

ASCO 2025 Insights Into HER2+ Breast Cancer: DESTINY-Breast09, PATINA, MINI Trial, and More

154

Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs

155

Highlights From ATS 2025: Approach to the Evaluation and Management of Interstitial Lung Abnormalities—The Official ATS Clinical Statement

156

Could a twice yearly injectable pre-exposure prophylaxis drug help curb the 44-year old HIV epidemic?

157

Emerging and Future Biomarkers for Interstitial Lung Disease

158

Advances and Future Treatment Targets for Interstitial Lung Disease

159

Can an oral diabetes drug reduce hepatic scarring from MASH?

160

The Role of MRD Testing in CLL

161

Toxicity and Treatment Management in CLL

162

CLL Debate: BTKi and BCL2i Combinations in Frontline Treatment of CLL

163

Breaking Barriers in CLL: Immunotherapy with CAR-T and Bispecific Antibodies

164

Can increased physical activity after adjuvant therapy for colon cancer improve disease-free survival?

165

Evolving CLL Therapy: The Power of Doublet and Triplet Regimens

166

Safety of Treatments for HER2-Mutant Lung Cancer

167

Advances in Treating HER2-Mutant Lung Cancer: Efficacy

168

What's fueling the rapid rise of measles in North America despite vaccine availability?

169

Could a new rescue inhaler strategy reduce severe asthma attacks in mild cases?

170

Could ending PEPFAR lead to 1 million new pediatric HIV cases by 2030?

171

Revisiting Anemia Response in Myelofibrosis: Revised International Working Group Criteria

172

Leukemic Transformation in Myelofibrosis: Risks, Realities, and Evolving Strategies

173

Understanding Secondary Myelofibrosis: Diagnosis, Treatment, and Prognosis

174

How much did maternal RSV vaccines and nirsevimab lower infant hospitalizations?

175

Migraine Missteps: Common Diagnostic Pitfalls and How to Avoid Them

176

Game Changer: Are CGRP Inhibitors the New First Line for Migraine Prevention?

177

Could a new HER2-targeted therapy change outcomes in previously treated NSCLC?

178

Lifestyle and Cognitive Health: A discussion with Drs. Elizabeth Kensinger and Andrew Budson

179

Could measles become endemic in the U.S. again within 25 years?

180

What does Mexico’s first fatal H5N1 avian flu case tell us about current risks to humans?

181

Could genetic testing improve prostate cancer screening beyond PSA?

182

Mary Beth Cicero on Reimagining the IUD: A Painless Future for Contraception

183

HER2+ Lung Cancer Treatment: Past, Present, and Future

184

Can statins reduce liver cancer risk in patients with chronic liver disease?

185

HER2 Alterations in Lung Cancer

186

HER2 Biomarker Testing in Lung Cancer

187

Migraine: Updates from the 2024 European Headache Congress

188

Could a new combination improve first-line therapy for myelofibrosis?

189

Migraine Debates: Initial Preventive Therapy and Status Migraine

190

Pharmacological Management of Postpartum Depression: Pros and Cons

191

Barriers to Care Engagement for Postpartum Depression

192

Suicide Risk in Postpartum Depression: Screening and Management

193

Could GLP-1 receptor agonists reduce the risk of blood cancers in type 2 diabetes patients?

194

Can AI reduce false positives and biopsies in breast ultrasound exams?

195

Osteoporosis: Common Questions and Clinical Conundrums

196

Operationalization of a Bisphosphonate “Drug Holiday”

197

Preservation of Perimenopausal Bone Health

198

What are the details around the first measles death in the US in 10 years?

199

Dr. Andrew Budson on consciousness and the role they play on memory

200

How severe is this flu season compared to recent years?

201

Navigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities

202

Navigating HER2+ Early Breast Cancer: Diagnosis, Treatment Planning, and De-Escalation

203

Why are measles outbreaks surging in Texas and New Mexico?

204

Specialist Spotlight: Parental favoritism and its impact on family dynamics and mental health

205

Specialist Spotlight: Marlie Tondac investigating learning and attention in young children.

206

Can a urine test reduce unnecessary prostate biopsies?

207

Could immunotherapy redefine treatment for Estrogen Receptor positive/HER2 negative breast cancer?

208

Approaching Tough Discussions in ILDs: Lung Transplantation and End-of-Life Issues

209

Insights Into Managing Comorbidities, Discussing Quality of Life, and Benefits of Pulmonary Rehab in Patients With ILDs

210

Could a fully human monoclonal antibody reduce bleeding risk in atrial fibrillation patients?

211

Principles of Selecting Pharmacotherapy for ILDs

212

Diagnosing and Classifying ILDs

213

What is the impact of red meat intake and the risk of dementia and cognitive decline?

214

The Process of Preparing Patients for Food Oral Immunotherapy – International Consensus for Procedural Preparation and Consent: Part 3

215

The Process of Preparing Patients for Food Oral Immunotherapy – International Consensus for Procedural Preparation and Consent: Part 2

216

The Process of Preparing Patients for Food Oral Immunotherapy – International Consensus for Procedural Preparation and Consent: Part 1

217

The Basics of HER2+ in Lung Cancers

218

2024 San Antonio Breast Cancer Symposium Insights on HER2+ Early Breast Cancer: MARGOT Trial, Risk-Reducing Surgeries/Survival, and More

219

What happens to patient care when private equity takes over hospitals?

220

2024 San Antonio Breast Cancer Symposium Insights on HER2+ Early Breast Cancer: TOUCH and DTP Trials and More

221

Clinical Trials in Myelofibrosis: Endpoints

222

Cytopenic Myelofibrosis

223

How many minutes of life does smoking 1 cigarette cost?

224

American Society of Hematology Annual Meeting 2024 – Updates in Myelofibrosis (Part 2)

225

American Society of Hematology Annual Meeting 2024 – Updates in Myelofibrosis (Part 1)

226

American Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 2)

227

American Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 1)

228

What factors are associated with loss to follow-up rates in patients with diabetic retinopathy or diabetic macular edema?

229

Could fewer allergies be linked the gut microbiota of children raised on farms or with pets?

230

Which population is most affected by the rising prevalence of anaphylaxis?

231

Could diet be fueling psoriasis flare-ups?

232

The Impact of Lifestyle and Stress on Memory and Cognition

233

Managing the Signs and Symptoms of Myelofibrosis

234

Clinical Trials in Myelofibrosis: Referral, Recruitment, and Assessment

235

What vaccine preventable disease is surging globally?

236

Postpartum Depression: Importance of Early and Effective Treatment

237

Screening and Diagnosis of Postpartum Depression

238

What is the risk of rhabdomyolysis in patients taking both SGLT2 inhibitors and statins?

239

Postpartum Depression: The Treatment Landscape

240

Shifting the Paradigm: Biologics in the Management of Food Allergy

241

Case-Based Approach to a Patient With Food Allergy

242

A Personalized Approach to Treating Patients With ANCA‑Associated Vasculitis

243

Can starting a medication abortion before confirming an intrauterine pregnancy offer a safe, effective alternative to waiting?

244

Induction Therapy in Patients With ANCA-Associated Vasculitis Part 2: Glucocorticoids and Plasma Exchange

245

Induction Therapy in Patients With ANCA-Associated Vasculitis Part 1: Induction Chemotherapy

246

The Future of Treating HER2+ Lung Cancer (Part 2)

247

Maintenance Therapy in ANCA-Associated Vasculitis

248

Steroid Reduction and Steroid Sparing Approaches to the Management of ANCA-Associated Vasculitis

249

The Future of Treating HER2+ Lung Cancer (Part 1)

250

ANCA-Associated Vasculitis: Renal Manifestations and Guideline Updates

251

Exploring HER2-Low and Ultralow in GI Cancers, Newer Therapies Targeting HER2, and Current Testing Methods

252

Goal-Directed Approach to Long-Term Management of Fracture Risk in Patients With Osteoporosis (Part 2)

253

Goal-Directed Approach to Long-Term Management of Fracture Risk in Patients With Osteoporosis (Part 1)

254

Navigating Toxicities in Gastroesophageal Cancer Treatment and Exploring HER2+ in Biliary Tract Cancers

255

Optimal Use of Denosumab in Patients With Postmenopausal Osteoporosis

256

Using Anabolic Agents in Patients With Postmenopausal Osteoporosis

257

The Role and Function of HER2+ in GI Cancers: Focus on Gastroesophageal and Colorectal Cancers

258

How does poor sleep in midlife impact brain health years later?

259

HER2+ in Gynecologic Cancers (Part 2)

260

HER2+ in Gynecologic Cancers (Part 1)

261

HER2+ Pan-Tumor Basics (Part 2)

262

HER2+ Pan-Tumor Basics (Part 1)

263

Which biologic treatment was the first to receive FDA approval for patients with uncontrolled COPD?

264

Specialist Spotlight: Daniel Daneshvar, MD, PhD on Traumatic Brain Injuries

265

Is hearing loss associated with increased risk of cognitive impairment?

266

What impact does defib pad position have on outcomes for cardiac arrest?

267

Advances in Migraine Treatment (Part 3)

268

Advances in Migraine Treatment (Part 2)

269

Advances in Migraine Treatment (Part 1)

270

Shifting the Focus: Proactive Prevention in Migraine Management

271

What's the first flu vaccine you can take at home?

272

Sinus Headache or Migraine? Unraveling the Truth

273

Treating Through Uncertainty: Selecting Migraine Treatment in Patients Considering Pregnancy

274

Approaches to Migraine Counseling and Treatment in Breastfeeding Patients

275

What is the latest on Cloud-Based AI Endoscopy?

276

What is the latest on the mpox outbreak in Africa and beyond?

277

What is the appropriate duration for beta-blockers after a myocardial infarction?

278

Long COVID affects adolescents differently than younger children

279

Specialist Spotlight: Dr. David Wohl on the current landscape in HIV treatment

280

Brain-computer interface enables man with ALS to speak again

281

Interstitial Lung Abnormalities as a Key Precursor to Interstitial Lung Disease (Part 2)

282

Interstitial Lung Abnormalities as a Key Precursor to Interstitial Lung Disease (Part 1)

283

Specialist Spotlight: Interstitial Lung Diseases for the Non‑Pulmonologist (Part 2)

284

Specialist Spotlight: Interstitial Lung Diseases for the Non‑Pulmonologist (Part 1)

285

FDA approves first nasal spray for treatment of anaphylaxis

286

The Role of Advanced Practice Providers in Diagnosing and Treating Interstitial Lung Diseases (Part 2)

287

The Role of Advanced Practice Providers in Diagnosing and Treating Interstitial Lung Diseases (Part 1)

288

Understanding HER2‑Low Breast Cancer: Challenges of Evolving Definition, Testing Approaches, and Treatment Decision‑Making

289

HER2 Testing in Breast Cancer: Clinical Relevance, Need, Testing Methods, Guidelines, and Interpretation of Results (Part 2)

290

Fourteen modifiable risk factors can help prevent dementia

291

HER2 Testing in Breast Cancer: Clinical Relevance, Need, Testing Methods, Guidelines, and Interpretation of Results (Part 1)

292

Twice-yearly lenacapavir provides 100% protection against HIV

293

Specialist Spotlight: Racial Disparities in Pulmonary Fibrosis (Part 3)

294

Specialist Spotlight: Racial Disparities in Pulmonary Fibrosis (Part 2)

295

Specialist Spotlight: Racial Disparities in Pulmonary Fibrosis (Part 1)

296

Study identifies racial disparities in opioid prescribing

297

Specialist Spotlight:Surgical Care of Patients With Osteoporosis

298

Specialist Spotlight: Perioperative Care of Patients With Osteoporotic Fractures

299

Specialist Spotlight: The Role of Nurse Practitioners and Physician Assistants in the Management of Patients With Postmenopausal Osteoporosis

300

Emerging Potential Treatment Options for Schizophrenia With Negative and Cognitive Symptoms (Part 2)

301

Investigational drug boosts pregnancy rates in women undergoing IVF, ICSI

302

Emerging Potential Treatment Options for Schizophrenia With Negative and Cognitive Symptoms (Part 1)

303

Specialist Spotlight: The Role of Assessment and Screening for Cognitive Impairment in Patients With Schizophrenia (Part 2)

304

Specialist Spotlight: The Role of Assessment and Screening for Cognitive Impairment in Patients With Schizophrenia (Part 1)

305

Specialist Spotlight: Recognizing the Three Symptoms Domains of Schizophrenia in the Outpatient Clinical Practice (Part 2)

306

FDA approves new drug for early Alzheimer's disease

307

Recognizing the Three Symptoms Domains of Schizophrenia in the Outpatient Clinical Practice (Part 1)

308

Islet cell transplantation may help some patients with type 1 diabetes achieve insulin independence

309

2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 3)

310

2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 2)

311

Weight maintenance possible following semaglutide, liraglutide discontinuation

312

2024 ASCO Highlights: Focus on HER2+ Breast Cancer (Part 1)

313

Lorlatinib shows unprecedented success in advanced NSCLC

314

Tattoo exposure associated with increased risk for malignant lymphoma

315

Novel technique shows promise for significant weight loss

316

Specialist Spotlight: Biosimilars in Retinal Medicine (Part 2)

317

Recovery possible for some patients with TBI removed from life support

318

Specialist Spotlight: Biosimilars in Retinal Medicine (Part 1)

319

Specialist Spotlight: Urothelial Carcinoma Update From the ASCO GU Symposium 2024

320

ASCO Genitourinary Symposium 2024: Late‑Breaking Presentations on EV‑302 and AMBASSADOR

321

Specialist Spotlight: Advanced Urothelial Carcinoma: Considerations in Therapeutic Sequencing

322

Changes in antibody levels predict which children will outgrow peanut allergies

323

Specialist Spotlight: Neoadjuvant Approach to Urothelial Carcinoma: Treatment With Curative Intent

324

Specialist Spotlight: Updates on the Diagnosis of High‑Risk Postmenopausal Osteoporosis (Part 2)

325

Specialist Spotlight: Updates on the Diagnosis of High‑Risk Postmenopausal Osteoporosis (Part 1)

326

USPSTF lowers recommended age for breast cancer screening

327

Secular differences in early life environment affect brain volume, dementia risk

328

Acetaminophen use during pregnancy not associated with neurodevelopmental disorders

329

Physician empathy impacts outcomes in patients with chronic pain

330

Remote monitoring can identify early signs of Alzheimer’s disease

331

More exposure to outdoor light at night linked to higher stroke risk

332

Specialist Spotlight: Alicia Morgans, MD, MPH on the Care of Cancer Survivors

333

No evidence of MRI-detectable brain injury in people with Havana Syndrome

334

Specialist Spotlight: Naushira Pandya, MD, CMD, FACP and Hady Masri, DO on the Unique Risks of the Geriatric Population and RSV: Part 2

335

Psychoactive cannabis use common among high school seniors

336

Specialist Spotlight: Raagini Jawa, MD, MPH, FASAM on Harm Reduction for Individuals with Substance Use Disorders

337

Specialist Spotlight: Jonathan E. Rosenberg, MD and Alicia K. Morgans, MD, MPH on Late‑Breaking Presentations on EV‑302 and AMBASSADOR at ASCO Genitourinary Symposium 2024

338

Specialist Spotlight: Naushira Pandya, MD, CMD, FACP and Hady Masri, DO on the Unique Risks of the Geriatric Population and RSV: Part 1

339

Generics for fingolimod associated with side effects, MS relapse

340

Specialist Spotlight: Alison Buttenheim, PhD on Vaccine Acceptance and Infectious Disease Prevention

341

Previously Untreated Advanced Urothelial Carcinoma: Update From ESMO 2023

342

Study Discussion: Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

343

Annual breast cancer screening at 40 saves lives

344

Abortion meds can be safely delivered through telemedicine

345

Three Symptom Domains of Schizophrenia: Positive, Negative, and Cognitive Impairment – Part 2

346

Long COVID increases risk for mental health disorders

347

Specialist Spotlight: Sanjai Rao, MD and Dawn Velligan, PhD on Symptom Domains of Schizophrenia in the Outpatient Setting (Part 1)

348

Alzheimer’s disease may be transmissable in rare cases

349

Specialist Spotlight: Raajit K. Rampal, MD, PhD and Ghaith Abu‑Zeinah, MD on Managing Splenomegaly in Myelofibrosis

350

COVID-19 pandemic had a profound impact on diabetes outcomes

351

Specialist Spotlight: Raajit K. Rampal, MD, PhD and Ghaith Abu‑Zeinah, MD on Sequencing JAK inhibitors in Myelofibrosis

352

HPV vaccine highly effective when administered early

353

Oral nirmatrelvir fails to reduce risk of long COVID

354

Modifiable risk factors for young-onset dementia identified

355

Specialist Spotlight: Dr. Krystal Kittle on Aging and Minority Communities

356

Blood test identifies patients at high risk for suicide

357

Specialist Spotlight: Ashton Applewhite on Ageism in Healthcare

358

Specialist Spotlight: Michaela Khan on Running Physiology

359

Specialist Spotlight: Dr. Cara Ocobock on Female Endurance

360

Discontinuation of tirzepatide leads to weight regain

361

Early treatment may induce remission in children born with HIV

362

Brain Care Score predicts dementia, stroke risk

363

Semaglutide reduces cardiovascular event risk in people without diabetes

364

Cat-borne parasite contributes to frailty in older adults

365

Experts create core outcomes set for long COVID

366

American Cancer Society updates lung cancer screening guidelines

367

Adult ADHD associated with increased risk for dementia

368

Long COVID is associated with reduced serotonin levels

369

Specialist Spotlight: Highlights From the 2023 Annual Meeting of American Society of Retina Specialists: Part 2

370

Specialist Spotlight: Highlights From the 2023 Annual Meeting of American Society of Retina Specialists: Part 1

371

Specialist Spotlight: What regimen for retinal disease? Drs. Schneider and Do on the PULSAR study 1-year data

372

Wastewater surveillance provides lead time for pediatric RSV season

373

Specialist Spotlight: How long between injections for retinal disease? Drs. Schneider and Do on the PHOTON study 2-year data

374

Specialist Spotlight: Dr. Tuan Vu on ALS and What's New in Neurology

375

Which therapies have the strongest evidence for smoking cessation?

376

Semaglutide shows promise in obesity-related heart failure

377

Specialist Spotlight: Dr. Chloe Zera Reflects One Year After the End of Roe v. Wade

378

Work stress increases risk for heart disease in men

379

Most older adults not aware of the new RSV vaccine

380

Specialist Spotlight: Does switching cost more? A cost analysis based on DRCR Network Protocol AC when treating patients

381

Specialist Spotlight: What to start DME patient on? A discussion of DRCR Network Protocol AC

382

Pharmacological duodenal exclusion therapy shows promise

383

Specialist Spotlight: Dallas Ducar on Providing Gender-Affirming Care (Part 2)

384

First 10 drugs named for Medicare price negotiations

385

Specialist Spotlight: Dallas Ducar on Providing Gender-Affirming Care (Part 1)

386

RSV in Adults Who Require Hospitalization and Their Management

387

Piroxicam boosts efficacy of emergency contraceptive pill

388

RSV Infections in Immunocompromised Adults

389

Playing football may increase risk of developing Parkinson's disease

390

Myelofibrosis: Updates from EHA 2023

391

Semaglutide reduces cardiovascular risk by 20%

392

Myelofibrosis: Updates from ASCO 2023

393

Topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (Part 2)

394

Universal flu vaccine elicits strong immune response

395

Topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (Part 1)

396

Insights from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology

397

Almost zero risk of HIV transmission with low viral loads

398

Specialist Spotlight on Diversity, Equity, and Inclusion in Retinal Medicine

399

Specialist Spotlight on Myelofibrosis: JAK inhibitor Drug Choice and Dosing Strategy

400

Specialist Spotlight on Myelofibrosis: Approach to Patients With Myelofibrosis and Anemia

401

Antibiotic exposure may affect COVID-19 severity

402

FDA approves first nonprescription oral contraceptive

403

Concomitant meds can hinder antidepressant response

404

Novel obesity drug leads to substantial weight loss

405

USPSTF recommends anxiety screening for all adults aged <65 years

406

Metformin reduces long COVID risk

407

Osimertinib is a game changer in NSCLC

408

Multidrug-resistant keratitis manageable when treated early

409

Oral therapy for sleep apnea could be a game changer

410

Children show good recovery after pediatric inflammatory multisystem syndrome

411

Specialist Spotlight: Clinical psychologist, Dr. Lisa Harris on the psychological impact of eating disorders, obesity, and diet culture

412

Desulfovibrio bacteria associated with Parkinson's disease

413

FDA approves first RSV vaccine for older adults

414

Specialist Spotlight: Dr. Lofton on weight management and the on-label and off-label uses of GLP-1 agonists

415

Brain changes observed in some patients with long COVID